You are here

  • Home
  • Archive
  • Volume 82, Issue 2
  • Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

Article metrics

Article menu
Download PDFPDF
Myositis
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

 

Online download statistics by month:

Online download statistics by month: August 2022 to March 2024

AbstractFullPdf
Aug 2022103510462
Sep 2022156214474
Oct 20225618042
Nov 20223596423
Dec 20221883613
Jan 20239428152
Feb 20235378747
Mar 20234606426
Apr 20233793828
May 20232402417
Jun 20231592411
Jul 20233822923
Aug 2023335209
Sep 20231671710
Oct 20232423216
Nov 20232593521
Dec 20232091816
Jan 20242652827
Feb 20241812619
Mar 20242462222
Total8708973558